 |
|
|
|
|
|
|
 |
Intended Use |
|
| |
|
|
|
GlucoDay® S, the latest Continuous Glucose Monitoring System from A. Menarini Research, was developed thanks to the collaborative relationship Menarini has with diabetologists all around Europe.
GlucoDay® S is a useful diagnostic tool for all clinical needs of a strict glycaemic control:
|
|
-
Type 1 diabetic patients
-
Nocturnal Hypoglycaemia
-
Hypoglycaemic Unawareness
-
Insulin-dependent Type 2 diabetic patients with unstable metabolic control
-
Set up and adjustment of Insulin therapy/Pump therapy
-
Gestational Diabetes
-
Paediatric Diabetes
-
Glycaemic monitoring in Intensive Care Units
|
|
|
|
GlucoDay® S includes advanced real-time capabilities, optional multi-point average calibration, improved accuracy in all ranges versus laboratory method, and more effective data management.
Intended Use:
-
To assess the adequacy of insulin regimen
-
To better program an insulin pump
-
To evaluate the adequacy of timing and frequency of self-monitored blood glucose
-
To adjust the glycaemic profile in the Gestational Diabetes management, for the prevention of maternal and fetal complications
-
To enhance patient education and psychological motivation for optimal diabetes management
|
|
Please be informed that the content of this page is intended for German residents only
|
|
|
|
|
|
|
